Jennison Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jennison Associates LLC

$155 Billion
Q2 2024

A detailed history of Jennison Associates LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 99,802 shares of REGN stock, worth $98.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

99,802

Previous 33,521 197.73%

Holding current value

$98.9 Million

Previous $32.3 Million 225.12%

% of portfolio

0.07%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $58.5 Million - $71 Million	66,281 Added 197.73%	99,802 $105 Million
Q1 2024 May 02, 2024	BUY	$902.69 - $993.35 $30.3 Million - $33.3 Million	33,521 New	33,521 $32.3 Million
Q1 2023 Apr 26, 2023	BUY	$680.49 - $826.97 $19.1 Million - $23.2 Million	28,090 New	28,090 $23.1 Million
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $980,981 - $1.21 Million	-1,805 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $1.04 Million - $1.23 Million	1,805 New	1,805 $1.09 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $4.76 Million - $5.62 Million	-10,061 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$446.73 - $548.2 $4.49 Million - $5.52 Million	10,061 New	10,061 $4.76 Million
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $32 Million - $40.7 Million	-66,884 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$544.75 - $658.21 $911,366 - $1.1 Million	-1,673 Reduced 2.44%	66,884 $37.4 Million
Q2 2020 Aug 06, 2020	BUY	$493.32 - $643.92 $10.9 Million - $14.3 Million	22,157 Added 47.75%	68,557 $42.8 Million
Q1 2020 May 06, 2020	BUY	$336.18 - $494.43 $14.5 Million - $21.3 Million	43,068 Added 1292.56%	46,400 $22.7 Million
Q2 2019 Aug 06, 2019	SELL	$299.6 - $414.82 $24,866 - $34,430	-83 Reduced 2.43%	3,332 $0
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $1.27 Million - $1.5 Million	3,415 New	3,415 $1.4 Million
Q2 2018 Aug 02, 2018	SELL	$284.6 - $344.99 $25.3 Million - $30.6 Million	-88,815 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$315.82 - $393.78 $4.11 Million - $5.13 Million	13,022 Added 17.18%	88,815 $30.6 Million
Q4 2017 Jan 25, 2018	SELL	$358.63 - $469.95 $403 Million - $528 Million	-1,123,954 Reduced 93.68%	75,793 $28.5 Million
Q3 2017 Nov 03, 2017	BUY	$431.38 - $504.0 $518 Million - $605 Million	1,199,747	1,199,747 $536 Million

Others Institutions Holding REGN

# of Institutions

1,467

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $106B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History